Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,582 | 54 | 99.5% |
| Gift | $17.24 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,230 | 15 | $0 (2020) |
| Aerie Pharmaceuticals, Inc. | $683.71 | 17 | $0 (2019) |
| Allergan, Inc. | $665.22 | 9 | $0 (2020) |
| Johnson & Johnson Vision Care, Inc. | $499.49 | 4 | $0 (2019) |
| Shire North American Group Inc | $150.88 | 3 | $0 (2018) |
| Genentech USA, Inc. | $126.59 | 1 | $0 (2018) |
| Genentech, Inc. | $115.79 | 1 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $45.39 | 2 | $0 (2020) |
| ABBVIE INC. | $41.05 | 1 | $0 (2022) |
| Tarsus Pharmaceuticals, Inc. | $23.29 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.29 | 1 | Tarsus Pharmaceuticals, Inc. ($23.29) |
| 2022 | $41.05 | 1 | ABBVIE INC. ($41.05) |
| 2020 | $218.40 | 5 | Allergan, Inc. ($145.87) |
| 2019 | $1,318 | 24 | Aerie Pharmaceuticals, Inc. ($536.12) |
| 2018 | $1,998 | 24 | Bausch & Lomb, a division of Bausch Health US, LLC ($821.85) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/09/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $41.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/09/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $34.45 | General |
| Category: Ophthalmology | ||||||
| 11/18/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: DRY EYE | ||||||
| 06/02/2020 | Carl Zeiss Meditec, Inc. | None Specified (Medical Supply) | Gift | In-kind items and services | $17.24 | General |
| 02/20/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $130.90 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $10.94 | General |
| Category: Ophthalmology | ||||||
| 11/07/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Glaucoma | ||||||
| 10/18/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Glaucoma | ||||||
| 09/26/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Glaucoma | ||||||
| 09/24/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/19/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Glaucoma | ||||||
| 09/05/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Glaucoma | ||||||
| 08/29/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Glaucoma | ||||||
| 06/26/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Glaucoma | ||||||
| 06/20/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/13/2019 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $122.94 | General |
| Category: DRY EYE | ||||||
| 06/12/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $124.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/06/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Glaucoma | ||||||
| 05/30/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $122.24 | General |
| Category: Glaucoma | ||||||
| 05/16/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Glaucoma | ||||||
| 05/16/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: Glaucoma | ||||||
| 05/09/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Glaucoma | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 417 | 418 | $62,318 | $22,784 |
| 2022 | 6 | 2,036 | 2,110 | $318,266 | $158,621 |
| 2021 | 7 | 175 | 183 | $33,970 | $8,868 |
| 2020 | 9 | 400 | 424 | $73,928 | $21,359 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 81 | 81 | $16,848 | $5,792 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $7,525 | $5,075 | 67.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 91 | 91 | $13,286 | $4,220 | 31.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 55 | 55 | $11,341 | $3,991 | 35.2% |
| 92250 | Photography of the retina | Office | 2023 | 116 | 117 | $10,125 | $2,601 | 25.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 31 | 31 | $3,193 | $1,104 | 34.6% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 509 | 509 | $105,872 | $54,536 | 51.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 492 | 528 | $77,088 | $38,014 | 49.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 299 | 299 | $62,192 | $36,949 | 59.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 243 | 281 | $28,943 | $15,367 | 53.1% |
| 92250 | Photography of the retina | Office | 2022 | 383 | 383 | $40,981 | $11,618 | 28.4% |
| 92285 | Photography of content of eyes | Office | 2022 | 110 | 110 | $3,190 | $2,135 | 66.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 41 | 47 | $8,110 | $4,359 | 53.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 37 | 38 | $10,336 | $1,260 | 12.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 21 | 22 | $3,300 | $1,250 | 37.9% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 37 | 37 | $4,440 | $859.60 | 19.4% |
| 92250 | Photography of the retina | Office | 2021 | 12 | 12 | $3,384 | $412.35 | 12.2% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 16 | 16 | $1,408 | $368.02 | 26.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 11 | 11 | $2,992 | $357.98 | 12.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 81 | 96 | $16,320 | $9,681 | 59.3% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 66 | 71 | $19,312 | $2,511 | 13.0% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 39 | 41 | $6,150 | $2,351 | 38.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 19 | 19 | $3,800 | $2,147 | 56.5% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2020 | 62 | 64 | $7,680 | $1,456 | 19.0% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2020 | 60 | 60 | $5,280 | $1,372 | 26.0% |
About Dr. Ashley Vu, OD
Dr. Ashley Vu, OD is a Optometrist healthcare provider based in Longmont, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1093245276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Vu, OD has received a total of $3,599 in payments from pharmaceutical and medical device companies, with $23.29 received in 2024. These payments were reported across 55 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($3,582).
As a Medicare-enrolled provider, Vu has provided services to 3,028 Medicare beneficiaries, totaling 3,135 services with total Medicare billing of $211,631. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Longmont, CO
- Active Since 06/19/2017
- Last Updated 02/07/2024
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093245276
Products in Payments
- Rhopressa (Drug) $683.71
- Acuvue (Device) $499.49
- VYZULTA (Drug) $404.48
- LUMIGAN (Drug) $380.27
- RESTASIS (Drug) $261.10
- BIOTRUE (Device) $171.73
- XIIDRA (Drug) $150.88
- LOTEMAX SM (Drug) $145.18
- Lucentis (Biological) $126.59
- BEPREVE (Drug) $125.00
- PROLENSA (Drug) $124.99
- ALREX (Drug) $122.60
- LOTEMAX (Drug) $118.01
- CEQUA (Drug) $45.39
- VUITY (Drug) $41.05
- COMBIGAN (Drug) $23.85
- XDEMVY (Drug) $23.29
- None Specified (Medical Supply) $17.24
- LOTEMAX GEL (Drug) $13.51
- ULTRA (Device) $4.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Longmont
Jane Wolford, Od, OD
Optometrist — Payments: $2,752
Dr. Anne-Marie Palmer, O.d, O.D
Optometrist — Payments: $1,989
Dr. Kevin Cottrell, O.d, O.D
Optometrist — Payments: $1,566
Clark Blackwood, O.d, O.D
Optometrist — Payments: $1,500
Dr. Robert Krone, Od, OD
Optometrist — Payments: $1,476
Alexandra Gutierrez, Od, OD
Optometrist — Payments: $1,169